8 results match your criteria: "Centro Hospitalar de Lisboa Ocidental E.P.E.[Affiliation]"
J Hypertens
January 2025
Critical Care Medicine Department, Division of Neurocritical Care, Hospital de Egas Moniz, Centro Hospitalar de Lisboa Ocidental E.P.E., Lisboa, Portugal.
Managing patients who present with elevated blood pressure (BP) requires careful but expeditious assessment and triage to differentiate between those at immediate risk of complications and those for whom BP elevation does not pose an immediate threat to health. We present a case of a 54-year-old healthy male patient who experienced refractory hypertension during the immediate postoperative period following nasal surgery. Additional gastrointestinal symptoms and imaging findings made it possible to consider a catecholamine-producing tumour as the primary cause.
View Article and Find Full Text PDFAnesth Analg
September 2024
From the Department of Anesthesiology, Centro Hospitalar de Setúbal E.P.E., Setúbal, Portugal.
Background: Dexamethasone is associated with increased blood glucose levels that could impact patient outcomes or management. This study aimed to synthesize the available evidence regarding the impact of an intraoperative single dose of dexamethasone on blood glucose levels.
Methods: We searched CENTRAL, MEDLINE, and clinicaltrials.
Rev Port Cardiol
May 2024
Hospital da Luz, Lisboa, Portugal; Hospital de São Bernardo, Centro Hospitalar de Setúbal E.P.E., Setúbal, Portugal.
Introduction And Objectives: Atrial fibrillation (AF) is the most common sustained arrhythmia, with significant burden for patients. Catheter ablation is safe and superior for symptom improvement. The purpose of this work was to assess how clinical practice compares with current scientific evidence and quality indicators for AF ablation.
View Article and Find Full Text PDFJ Vasc Access
March 2024
Nephrology Department, Centro Hospitalar de Lisboa Ocidental E.P.E., Hospital de Santa Cruz, Lisbon, Portugal.
Neurol Sci
February 2021
Centro Hospitalar e Universitário de Coimbra, Praceta Prof. Mota Pinto, 3000-075, Coimbra, Portugal.
Neurol Sci
May 2021
Centro Hospitalar e Universitário de Coimbra, Praceta Prof. Mota Pinto, 3000-075, Coimbra, Portugal.
Background: Fingolimod, an oral sphingosine 1-phosphate receptor modulator, is approved by EMA for relapsing-remitting multiple sclerosis (RRMS).
Objectives: To assess the effectiveness and safety of fingolimod in patients with RRMS in real-world clinical practice in Portugal.
Methods: Retrospective, multicentre, non-interventional study, reporting 3 years follow-up of data collected from October 2015 to July 2016.
J Clin Rheumatol
December 2021
Rheumatology Department, Unidade Local de Saúde do Alto Minho, Ponte de Lima.
Background: Ultrasonography is an image technique that allows rheumatologists to visualize structural and inflammatory changes within a joint. The objective of this study was to assess the interobserver and intraobserver reliability of musculoskeletal ultrasound (US) in the detection of inflammatory and destructive joint changes in patients with polyarthritis.
Methods: A Delphi exercise was undertaken to standardize and adapt the EULAR-OMERACT elementary US definitions of inflammatory lesions (effusion, synovial hypertrophy, power Doppler, bone erosions, and synovitis) for each joint.
J Clin Rheumatol
September 2014
From the *Rheumatology Department, Centro Hospitalar de Lisboa Ocidental E.P.E, Hospital de Egas Moniz; and †CEDOC, NOVA Medical School/Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon; and ‡USF Arco-íris, ACES Amadora, Portugal.